Delivery Order SPE2DB22D1106-SPE2DB25FEYS0
Award Date 7/18/25
Potential Completion Date 7/21/25
Potential Value $7.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Fycompa 0.5 mg/mL oral suspension in a 340 mL quantity, with a contract value of $2,903.46. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order is executed...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,027.44 for Fycompa 8 mg tablets (30-count) with an ultimate completion date of September 5, 2025. This competitive delivery order, issued under firm fixed-price terms with no set-aside designation, represents a single pharmaceutical supply transaction fulfilled from the contractor's place of performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $12,464.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for FYCOMPA 0.5 mg/ml oral suspension (340 ml) on August 25, 2025, with completion scheduled for August 26, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026. The performance location...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,072.56 to AmerisourceBergen Drug Corp for 30 tablets of Fycompa 6 mg on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. Fycompa is an antiepileptic medication used to treat partial-onset seizures, reflecting AmerisourceBergen's role...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Fycompa 0.5 mg/ml oral suspension in a 340 ml quantity, valued at $13,461.85 under a firm fixed price contract. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026 that serves as a comprehensive global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of FYCOMPA 12 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $2,152.34. This is a competitively awarded, non-set-aside delivery order with an ultimate completion date of August 1, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for Fycompa 8 mg tablets (30-count units) with a ceiling value of $1,713.96. This firm fixed-price delivery order, which is expected to be completed by June 4, 2025, represents a continuation of AmerisourceBergen's significant role as a pharmaceutical supplier to the federal government. The award was made without a set-aside designation, indicating open competition. The performance location is...
- The Defense Logistics Agency awarded a delivery order valued at $2,111.20 to AmerisourceBergen Drug Corp for the supply of Fycompa 4 mg tablets (30-count units) on July 10, 2025, with completion scheduled for July 11, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and was performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 14, 2025, valued at $1,489.87 for the supply of Fycompa 2 mg tablets (30-count packages) under a firm fixed price contract. This is a non-set-aside, competitively awarded delivery order issued by the Defense Logistics Agency's Medical Supply Chain, a component of the Department of Defense. The place of performance is listed as the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $1,580.41 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fycompa 8 mg tablets (30-count packages). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and a completion date of July 22, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's place of performance. This...